Biological E gets WHO pre-qualification status for oral polio vaccine Ruchika Sharma31 July 2024 11:38 AM IST Hyderabad: In a stride towards eradicating polio worldwide, Biological E. Limited (BE), a Hyderabad-based vaccine and pharmaceutical company has...
Himachal to develop Nalagarh Medical Park with state resources, returns Central Rs 30 Crore Ruchika Sharma30 July 2024 5:23 PM ISTShimla: Prioritizing state interests, the Himachal Pradesh government has decided to independently build a medical device park in Nalagarh, Solan...
Strides Pharma Q1 results: Net profit at Rs 84 crore vs net loss of Rs 29.5 crore a year ago Ruchika Sharma30 July 2024 4:24 PM ISTBangalore: Strides Pharma Science has announced a profit after tax (PAT) from continuing operations of Rs 84 crore for the first quarter ended...
Cipla to begin supplies from China facility to US later this year Ruchika Sharma30 July 2024 12:35 PM ISTPharmaceutical giant Cipla expects to begin supplies from its China-based facility to the US market in the latter half of the current fiscal year,...
Dr Reddy's Labs reports marginal decline in profit in Q1 Ruchika Sharma30 July 2024 10:30 AM ISTNew Delhi: Dr Reddy's Laboratories reported a marginal decline in its consolidated profit after tax (PAT) for the first quarter ending June 30,...
Strides Pharma Science arm incorporates company in New Zealand Ruchika Sharma29 July 2024 4:03 PM ISTMumbai: Strides Pharma Science has announced that Strides Pharma Global Pte. Limited, Singapore, a step-down wholly owned subsidiary of the...
Sanivarapu Ravi Prakash Reddy resigns as Natco Pharma Senior Vice President - Operations Ruchika Sharma29 July 2024 3:18 PM ISTHyderabad: Natco Pharma has announced that Sanivarapu Ravi Prakash Reddy, Senior Vice President - Operations, Pharma Division, Kothur, Rangareddy...
Indoco Remedies gets 7 USFDA observations for Goa facilities Ruchika Sharma29 July 2024 2:22 PM ISTMumbai: Through a recent BSE filing, Indoco Remedies has informed that the Company has received seven observations in Form 483 from the...
USFDA concludes inspection at Biocon Biologics Bengaluru facilities Ruchika Sharma29 July 2024 12:53 PM ISTBengaluru: The U.S. Food and Drug Administration (USFDA) has concluded a combined cGMP inspection and PreLicensing Inspection (PLI) at...
Dr Reddy's Labs gets positive EMA Committee opinion for proposed Rituximab biosimilar Ruchika Sharma29 July 2024 11:30 AM ISTHyderabad: Dr Reddy's Laboratories Ltd., today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human ...
CDSCO Panel Approves AstraZeneca's Protocol Amendment Proposal to Study anti-cancer Drug Capivasertib Dr. Divya Colin28 July 2024 6:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved AstraZeneca's...
FDA Advisory Committee reviewed Imfinzi for resectable non-small cell lung cancer based on AEGEAN Phase III trial results Ruchika Sharma28 July 2024 4:15 PM ISTThe Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) has acknowledged that AstraZeneca's Imfinzi (durvalumab) met...
